Tenon Medical Inc. logo

Tenon Medical Inc. (TNON)

Market Closed
12 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 17
+0.03
+2.19%
$
9.72M Market Cap
- P/E Ratio
0% Div Yield
163,065 Volume
-3.15 Eps
$ 1.14
Previous Close
Day Range
1.11 1.17
Year Range
0.85 5.85
Want to track TNON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TNON closed today higher at $1.17, an increase of 2.19% from yesterday's close, completing a monthly increase of 4.95% or $0.05. Over the past 12 months, TNON stock lost -39.95%.
TNON is not paying dividends to its shareholders.
The last earnings report, released on Nov 13, 2025, exceeded the consensus estimates by 0.37%. On average, the company has surpassed earnings expectations by 0.24%, based on the last three reports.
Tenon Medical Inc. has completed 2 stock splits, with the recent split occurring on Sep 06, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

TNON Chart

Similar

Cytosorbents Corporation
$ 0.65
-8.87%
Kalaris Therapeutics, Inc.
$ 9.81
+4.14%
CUE
Cue Biopharma Inc.
$ 0.48
-2.27%
Spectral AI Inc.
$ 1.6
-6.69%
IceCure Medical Ltd.
$ 0.67
-3.5%
Tenon Medical, Inc. (TNON) Q3 2025 Earnings Call Transcript

Tenon Medical, Inc. (TNON) Q3 2025 Earnings Call Transcript

Tenon Medical, Inc. ( TNON ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Steven Foster - CEO, President & Director Kevin Williamson - Chief Financial Officer Conference Call Participants Scott Henry - Alliance Global Partners, Research Division Thomas McGovern Presentation Operator Greetings, and welcome to the Tenon Medical Third Quarter 2025 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded.

Seekingalpha | 4 weeks ago
Tenon Medical, Inc. (TNON) Q2 2025 Earnings Call Transcript

Tenon Medical, Inc. (TNON) Q2 2025 Earnings Call Transcript

Tenon Medical, Inc. (NASDAQ:TNON ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Kevin Williamson - Chief Financial Officer Steven M. Foster - CEO, President & Director Conference Call Participants Nicholas Sherwood - Maxim Group LLC, Research Division Scott Robert Henry - Alliance Global Partners, Research Division Operator Greetings, and welcome to the Tenon, Inc. Second Quarter 2025 Earnings Conference Call.

Seekingalpha | 4 months ago
Tenon Medical, Inc. (TNON) Q1 2025 Earnings Call Transcript

Tenon Medical, Inc. (TNON) Q1 2025 Earnings Call Transcript

Tenon Medical, Inc. (NASDAQ:TNON ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Steve Foster - President & Chief Executive Officer Kevin Williamson - Chief Financial Officer Conference Call Participants Scott Henry - Alliance Global Partners Nicholas Sherwood - Maxim Group Operator Greetings. And welcome to the Tenon Medical First Quarter 2025 Financial Results and Corporate Update Conference Call.

Seekingalpha | 7 months ago

Tenon Medical Inc. (TNON) FAQ

What is the stock price today?

The current price is $1.17.

On which exchange is it traded?

Tenon Medical Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is TNON.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 9.72M.

Has Tenon Medical Inc. ever had a stock split?

Tenon Medical Inc. had 2 splits and the recent split was on Sep 06, 2024.

Tenon Medical Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Steven M. Foster CEO
NASDAQ (CM) Exchange
88066N303 CUSIP
US Country
27 Employees
- Last Dividend
6 Sep 2024 Last Split
27 Apr 2022 IPO Date

Overview

Tenon Medical, Inc. is a notable medical device company with a focused mission to innovate in the field of surgical implant systems, specifically targeting the enhancement of sacroiliac joint fixation/fusion surgery outcomes. The company has been pioneering in this specialty since its establishment in 2012. Operating from its headquarters in Los Gatos, California, Tenon Medical has dedicated itself to addressing the unique challenges faced by surgeons and patients alike in sacroiliac joint surgeries. Through its commitment to advancing medical technology and improving surgical results, Tenon Medical has made significant strides in offering solutions that aim to reduce pain, improve mobility, and enhance the quality of life for patients suffering from sacroiliac joint dysfunctions.

Products and Services

  • The CATAMARAN SIJ Fusion System
  • This innovative product by Tenon Medical stands at the core of its offerings. It comprises a comprehensive set of instruments and implants specifically designed for the surgical preparation and fixation of the Sacroiliac Joint (SI-Joint) for fusion. The CATAMARAN SIJ Fusion System showcases the company's commitment to advancing surgical techniques and outcomes in sacroiliac joint fusion surgeries. The system is marketed in the United States and Puerto Rico, where it has been adopted by surgeons looking for reliable and effective solutions for SI-Joint dysfunctions. The focus on precision instruments and quality implants reflect Tenon Medical's dedication to excellence in medical device development.

Contact Information

Address: 104 Cooper Court
Phone: (408) 649-5760